Barry A L, Fuchs P C, Thornsberry C, McLaughlin J C, Jenkins S G, Hardy D J, Allen S D
Clinical Microbiology Institute, Tualatin, Oregon 97062, USA.
Eur J Clin Microbiol Infect Dis. 1996 Aug;15(8):676-8. doi: 10.1007/BF01691158.
Three methods approved by the National Committee for Clinical Laboratory Standards for testing the susceptibility of anaerobic bacteria were used to evaluate the fluoroquinolone, trovafloxacin. The methods gave essentially comparable results with 126 anaerobes and with three quality control strains. A collaborative study defined the quality control range for trovafloxacin MICs. Trovafloxacin had good in vitro activity against the more common anaerobes (MIC 90 < = or 2.0 micrograms/ml).
美国国家临床实验室标准委员会批准的三种检测厌氧菌药敏性的方法被用于评估氟喹诺酮类药物曲伐沙星。这些方法对126株厌氧菌和三种质量控制菌株得出了基本可比的结果。一项协作研究确定了曲伐沙星最低抑菌浓度(MIC)的质量控制范围。曲伐沙星对较常见的厌氧菌具有良好的体外活性(MIC90≤2.0微克/毫升)。